This report examines the causes and effects of an increasing global resistance to antibiotics: from the pressures doctors are under to prescribe them even for viral infections, to what new treatments are currently in the pipeline, as well as what role can the consumer play in reducing antibiotic use in the food chain

• Antibiotic resistance kills over 1m people a year, says study

  Research underscores the dangers of bacteria developing the ability to resist drugs

  
• Antibiotic accountability: how countries and companies perform

  FT dashboard tracks responses to the growing threat of antimicrobial resistance

  
• Limited access to antibiotics is driving resistance, warns watchdog

  Failure to ensure they reach world’s poorest increases health risks, says pharma body

  
• Pressure grows for funding to tackle ‘silent pandemic’ of antimicrobial resistance

  Political will is needed to address absence of sufficient financial incentives for new drugs

  
• Push and pull: funding drugs to be used only sparingly

  New models are emerging to allow pharma companies to turn a profit regardless of how much new antibiotics are used

  
• Video: Do we need a Netflix for antibiotics?

  FT’s Andrew Jack analyses new subscription models to pay for breakthrough medicines

  

• The silent pandemic of antibiotic resistance

  A South African doctor’s prescription to stop poorer countries losing access to many of modern medicine’s advances

  
• Antibiotic resistance: how to tackle a public health crisis

  Recommendations from two FT roundtables with pharma, government, and NGO experts

  
• Overuse of antibiotics for meat production drives resistance in humans

  Household names like McDonald’s start to modify practices to aid farm animals’ health, growth and digestion

  
• Covid delays India’s attempts to curb widespread overuse of antibiotics

  Some hospital schemes encourage proper antimicrobial stewardship but progress has been slow

  
• The threat of antibiotic resistance — in charts

  Detailed information is starting to emerge on the problem and how to combat it

  
• Non-profits fill gaps in the broken market for antibiotics

  Promising treatments in pipeline despite lack of financial incentives for pharma industry

  
• Countries brace for ‘silent tsunami’ of antibiotic-resistant infections

  Over half a century after antibiotics revolutionised medicine, overuse threatens existing treatments while the pipeline of replacements is thin

  
• Investors step up pressure on companies over use of antibiotics

  Amundi and Aviva among backers of initiative targeting food, retail and pharmaceutical groups

  
• Video: How can we stop the next global health crisis?

  In the future even cuts can have fatal consequences, with drug resistant infections killing 10m people a year. Is this just a projection?

  
• Antimicrobial resistance is the next battle

  Covid-19 is a warning that we must develop drugs to treat future threats